Analyst Price Targets — CTM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 24, 2025 11:56 am | Allen Klee | Maxim Group | $3.00 | $0.99 | TheFly | Castellum initiated with a Buy at Maxim |
Latest News for CTM
Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a Good Manufacturing Practice (GMP) batch of clinical trial material (CTM) for its lead product candidate.
VIENNA, Va., March 04, 2026 (GLOBE NEWSWIRE) -- Castellum, Inc. (“Castellum” “CTM”, “we” or the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces certain unaudited highlights of its operating results for its year ended December 31, 2025.
Castellum AB (publ) (CWQXY) Q4 2025 Earnings Call Transcript
VIENNA, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) ("Castellum" or "CTM"), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that it has retired in full the $400,000 principal balance on its sole remaining note payable to Emil Kaunitz.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CTM.
U.S. House Trading
No House trades found for CTM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.